Yutong Yang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Patient Expectations, Safety Concerns, and Adherence to Topical Acne Medications: Findings from a Web-Based Survey.

Patient Expectations, Safety Concerns, and Adherence to Topical Acne Medications: Findings from a Web-Based Survey.

Journal: Patient preference and adherence

Published: March 27, 2026

Targeting Macrophage-to-Myofibroblast Transition Mitigates Progression from Inflammation to Fibrosis in Rosacea.

Targeting Macrophage-to-Myofibroblast Transition Mitigates Progression from Inflammation to Fibrosis in Rosacea.

Journal: International journal of biological sciences

Published: November 22, 2025

Comparative analysis of recurrence rates: Day-light versus red-light photodynamic therapy in the treatment of actinic keratosis during a five-year follow-up.

Comparative analysis of recurrence rates: Day-light versus red-light photodynamic therapy in the treatment of actinic keratosis during a five-year follow-up.

Journal: Photodiagnosis and photodynamic therapy

Published: February 10, 2025

IPL-PDT as an effective treatment for mild-to-moderate acne vulgaris: A prospective, single-center, self-controlled study.

IPL-PDT as an effective treatment for mild-to-moderate acne vulgaris: A prospective, single-center, self-controlled study.

Journal: Photodiagnosis and photodynamic therapy

Published: December 03, 2023

Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU).

Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU).

Journal: The Australasian journal of dermatology

Published: October 12, 2023

Modified red light 5-aminolevulinic acid photodynamic therapy versus low-dose isotretinoin therapy for moderate to severe acne vulgaris: A prospective, randomized, multicenter study.

Modified red light 5-aminolevulinic acid photodynamic therapy versus low-dose isotretinoin therapy for moderate to severe acne vulgaris: A prospective, randomized, multicenter study.

Journal: Journal of the American Academy of Dermatology

Published: February 17, 2023

5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study.

5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study.

Journal: Journal of the American Academy of Dermatology

Published: December 08, 2022

Topical 5-aminolevulinic acid photodynamic therapy with novel approach successfully treated refractory deep male urethral condyloma acuminata: A retrospective case series.

Topical 5-aminolevulinic acid photodynamic therapy with novel approach successfully treated refractory deep male urethral condyloma acuminata: A retrospective case series.

Journal: Journal of the American Academy of Dermatology

Published: August 11, 2022

Efficacy and therapeutic reactions of tri-needle-pretreatment combined with painless ALA-PDT for the treatment of moderate-to-severe acne vulgaris: A randomized controlled trial.

Efficacy and therapeutic reactions of tri-needle-pretreatment combined with painless ALA-PDT for the treatment of moderate-to-severe acne vulgaris: A randomized controlled trial.

Journal: Photodiagnosis and photodynamic therapy

Published: September 29, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026